Oxford Nanopore Technologies (LON:ONT) Price Target Cut to GBX 225 by Analysts at Royal Bank Of Canada

Oxford Nanopore Technologies (LON:ONT) had its price objective cut by Royal Bank Of Canada from GBX 300 to GBX 225 in a research report released on Tuesday morning, Marketbeat reports. They currently have an outperform rating on the stock.

Several other equities research analysts have also recently issued reports on ONT. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Oxford Nanopore Technologies from GBX 210 to GBX 225 and gave the stock a “buy” rating in a research report on Thursday, January 22nd. Peel Hunt restated a “hold” rating and issued a GBX 153 price target on shares of Oxford Nanopore Technologies in a research note on Friday, December 5th. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 250 price target on shares of Oxford Nanopore Technologies in a report on Thursday, January 22nd. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Oxford Nanopore Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 218.60.

Oxford Nanopore Technologies Stock Up 1.6%

Shares of LON:ONT opened at GBX 117.20 on Tuesday. Oxford Nanopore Technologies has a fifty-two week low of GBX 96.35 and a fifty-two week high of GBX 224.80. The firm’s 50 day moving average price is GBX 137.47 and its 200 day moving average price is GBX 139.59. The company has a quick ratio of 6.01, a current ratio of 3.56 and a debt-to-equity ratio of 8.96. The stock has a market cap of £1.13 billion, a price-to-earnings ratio of -7.92 and a beta of 0.83.

Oxford Nanopore Technologies (LON:ONT) last posted its quarterly earnings results on Monday, March 2nd. The company reported GBX (15.10) EPS for the quarter. Oxford Nanopore Technologies had a negative return on equity of 29.43% and a negative net margin of 64.85%.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.